Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Naghmeh Khavandgar
Observed names:
Khavandgar, Naghmeh,
N. Khavandgar
Institutions:
University of Kansas Medical Center,
Research Center for Chronic Inflammatory Diseases,
Digestive Disease Research Institute,
Tehran University of Medical Sciences
Observed institutions:
University of Tehran,
Shariati Hospital,
University of Kansas Medical Center,
Research Center for Chronic Inflammatory Diseases,
Rheumatology Research Center,
Digestive Disease Research Institute,
Tehran University of Medical Sciences
show all 7
ORCID:
0009-0003-6353-7884
Observed ORCIDs:
0009-0003-6353-7884,
0000-0002-8890-157X
OpenAlex ID:
A5002060908
Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series
2021
·
Seyed-Mohammad Reza Hashemian
, Rasoul Aliannejad
, et al.
·
Stem Cell Research & Therapy
·
213
Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: a randomized controlled trial
2023
·
Morteza Zarrabi
, Mohammad Amin Shahrbaf
, et al.
·
Stem Cell Research & Therapy
·
99
PDF
Hematopoietic Stem Cell Transplantation in Sickle Cell Disease: A Multidimentional Review
2024
·
Tahereh Rostami
, Soroush Rad
, et al.
·
Cell Transplantation
·
25
Graft failure after allogeneic hematopoietic stem cell transplantation in pediatric patients with acute leukemia: autologous reconstitution or second transplant?
2024
·
Tahereh Rostami
, Mohammad Reza Rostami
, et al.
·
Stem Cell Research & Therapy
·
21
PDF
Outcomes with chimeric antigen receptor T-cell therapy in Rheumatological disorders: A systematic review
2024
·
Fizza Zulfiqar
, Moazzam Shahzad
, et al.
·
Transplant Immunology
·
16
Global Research Trends on Colorectal Cancer (2014-2023): A Scientometric and Visualized Study
2024
·
Iman Menbari Oskouie
, Hediyeh Alemi
, et al.
·
Archives of Iranian Medicine
·
12
PDF
Comparable Outcomes of Pre- Versus Post-Tyrosine Kinase Inhibitor Era Treatment in Chronic Myeloid Leukemia: A Retrospective Cohort Study With Long-term Follow-up
2023
·
Sahar Tavakoli
, Fattaneh Khalaj
, et al.
·
Cell Transplantation
·
3
Comparison of clinicodemographic characteristics and pattern of vascular involvement in 126 patients with Takayasu arteritis: a report from Iran and Turkey
2022
·
Z. Tamartash
, A. Javinani
, et al.
·
Reumatismo
·
3
PDF
Association of EASIX Score with Non-relapse Mortality and Overall Survival in Pediatric Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
2025
·
Amir Kasaeian
, Azadeh Kiumarsi
, et al.
·
Stem Cell Reviews and Reports
·
2
Advances in targeted therapies by PARP inhibitors for the treatment of prostate cancer: A scientometric approach
2025
·
Iman Menbari Oskouie
, Naghmeh Khavandgar
, et al.
·
Urologia Journal
·
2
Global research trends on systemic lupus erythematosus and thyroid cancers (1964–2023): A scientometric and visualized study
2024
·
Hediyeh Alemi
, Naghmeh Khavandgar
, et al.
·
Medicine
·
2
Advances in Radiotherapy and Chemoradiotherapy for the Treatment of Gastric Cancer (2014-2023): A Scientometric Approach
2025
·
Iman Menbari Oskouiee
, Naghmeh Khavandgar
, et al.
·
Medical Journal of the Islamic Republic of Iran
·
1
PDF
Incidence and Severity of Cytopenias Secondary to CD19-Targeted CAR-T Cell Therapy: A Systemic Review and Meta-Analysis
2025
·
Moazzam Shahzad
, Abhinav Vyas
, et al.
·
Transplantation and Cellular Therapy
·
1
Outcomes after Bone Marrow Versus Peripheral Blood Haploidentical Hematopoietic Cell Transplantation Using Posttransplant Cyclophosphamide-Based Gvhd Prophylaxis
2024
·
Muhammad Umair Mushtaq
, Amir Kasaeian
, et al.
·
Blood
·
1
Sociodemographic and Patient-Related Determinants of Outcomes after Matched Sibling Donor Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based GvHD Prophylaxis
2024
·
Sibgha Gull Chaudhary
, Moazzam Shahzad
, et al.
·
Blood
·
1
PDF
Factors Associated with Graft-Versus-Host Disease after Related Donor Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based GvHD Prophylaxis
2024
·
Muhammad Umair Mushtaq
, Amir Kasaeian
, et al.
·
Blood
·
1
Outcomes after Bone Marrow Versus Peripheral Blood Matched Unrelated Donor Hematopoietic Stem Cell Transplantation for Acute Leukemia
2024
·
Muhammad Umair Mushtaq
, Amir Kasaeian
, et al.
·
Blood
·
1
Impact of CD34+ graft cell dose on acute GVHD and engraftment in matched sibling donor peripheral blood stem cell transplantation with post-transplant cyclophosphamide prophylaxis: a CIBMTR analysis
2026
·
Moazzam Shahzad
, Muhammad Kashif Amin
, et al.
·
Bone Marrow Transplantation
PDF
Outcomes After Matched Sibling Donor Versus Haploidentical Hematopoietic Stem Cell Transplantation With Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis
2026
·
Muhammad Umair Mushtaq
, Amir Kasaeian
, et al.
·
Transplantation and Cellular Therapy
PDF
Combination of post-transplant cyclophosphamide and anti-thymocyte globulin for haploidentical stem cell transplantation in pediatric patients with acute leukemia
2026
·
Azadeh Kiumarsi
, Tahereh Rostami
, et al.
·
Discover Oncology
Factors associated with outcomes following reduced intensity conditioning haploidentical hematopoietic cell transplantation in acute myeloid leukemia.
2025
·
Muhammad Umair Mushtaq
, Muhammad Kashif Amin
, et al.
·
Journal of Clinical Oncology
PDF
Scientific Knowledge of Wegener's Granulomatosis: A Scientometric Analysis, From 1970 to 2023
2025
·
Amir Kasaeian
, Majid Alikhani
, et al.
·
Journal of Biostatistics and Epidemiology
Impact of Graft Cell Dose on Outcomes after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis
2025
·
Muhammad Umair Mushtaq
, Amir Kasaeian
, et al.
·
Transplantation and Cellular Therapy
Outcomes after Matched Sibling Donor Versus Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based GvHD Prophylaxis
2025
·
Muhammad Umair Mushtaq
, Amir Kasaeian
, et al.
·
Transplantation and Cellular Therapy
Outcomes after Matched Sibling Donor Versus Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based GvHD Prophylaxis
2024
·
Muhammad Umair Mushtaq
, Amir Kasaeian
, et al.
·
Blood
PDF
Show more works
View as search
Works count:
43
Citation count:
404
H-index:
6
I10-index:
6
Year
Topic
Type